Trademark: 79290571
Word
...ICHNOS...
Status
Registered
Status Code
700
Status Date
Tuesday, November 9, 2021
Serial Number
79290571
Registration Number
6549554
Registration Date
Tuesday, November 9, 2021
Mark Type
5000
Filing Date
Wednesday, May 6, 2020
Published for Opposition
Tuesday, August 24, 2021

Trademark Owner History
Ichnos Sciences SA - Original Registrant

Classifications
41 Educational services, namely, providing workshops and seminars in the fields of cancer treatment, oncology, immunology and pain management; publication of journals featuring research articles and clinical trials for pharmaceutical preparations; education services, namely, conducting online instruction and courses in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; provision of educational content, namely, providing on-line instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine, medical diseases, disorders and related treatments; training in the use and operation of medical devices, medical imaging apparatus and medical research apparatus and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, lectures, panel discussions, and training programs in the field of pharmaceutical products, healthcare and medical diseases, disorders and related treatments; educational services, namely, providing non-downloadable webinars in the field of health and medical information and distribution of course material in connection therewith; education services, namely, developing, arranging and conducting educational programs and providing courses of instruction in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; providing training programs and developing training programs in the nature of learning methodologies for others relating to the use and operation of medical devices, medical research apparatus and consultation relating thereto; providing online non-downloadable publications, namely, instructional materials in the nature of worksheets and textbooks, featuring study materials in the field of pharmaceutical products, healthcare and medical diseases, disorders and related treatments; conducting educational seminars in the fields of healthcare, the use of pharmaceuticals, and medical devices, medical research, surgery, medical science and medicine
5 Pharmaceutical preparations for human use for the treatment of respiratory disorders; nasal spray preparations; medical and pharmaceutical preparations, namely, inhaler preparations for treatment of Chronic Obstructive Pulmonary Disease (COPD); preparations containing opium alkaloids; pharmaceutical anti-allergic preparations and substances; pharmaceutical antitussivecold preparations; * pharmaceutical products for the treatment of erectile dysfunction; * pharmaceutical preparations for the treatment of gout; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances used in the treatment of gastro-intestinal diseases; pharmaceutical preparations for animal skincare; pharmaceutical preparations for inhalation used in the treatment of pulmonary hypertension; pharmaceutical preparations for skin care; pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, and for the treatment of inflammatory disorders, and for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in chemotherapy; pharmaceutical and biological preparations for the treatment of cancer; dermatological pharmaceutical preparations; pharmaceutical preparations for use in urology ; pharmaceutical preparations for wounds; pharmaceutical preparations, namely, antidepressants; pharmaceutical preparations, namely, appetite suppressants; pharmaceutical preparations, namely, blood clotting aid and delivery systems for use in human and veterinary medicine; pharmaceutical preparations, namely, drug delivery systems comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; pharmaceutical preparations, namely, anticoagulants; pharmaceutical products and preparations against dry skin caused by pregnancy; medicated skin care preparations; medicated skin care preparations, namely, gels; pharmaceutical products and preparations for chloasma; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for pregnancy blemishes; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products and preparations for preventing swelling in the legs; pharmaceutical products for ophthalmological use; pharmaceutical products for skin care for animals; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of joint diseases; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical skin lotions; pharmaceutical solutions used in dialysis; pharmaceuticals for the treatment of erectile dysfunction; pharmaceuticals, namely, anti-infectives; pharmaceuticals, namely, antihelminthics; pharmaceuticals, namely, inducers of erections; pharmaceuticals, namely, lipid lowering agents; analgesic preparations; preparations for the treatment of asthma; preparations for therapeutic or medical purposes, namely, therapeutic medicated skin preparations for treatment of skin diseases; decongestant nasal sprays
3 Soaps for cosmetic use, namely, cosmetic soaps; skin soaps; shampoos; sunscreens for cosmetic use; perfumery products, namely, perfumery, deodorants for personal use; essential oils; body powders; cosmetic products, namely, cosmetics; antiaging creams; hair lotions; cosmetic skin care preparations; skin creams; skin moisturizing gels; face washing creams, facial cleansers, washing products for facial treatment in the nature of non-medicated soaps; moisturizing body lotions; non-medicinal mouthwashes
35 Advertising services for promoting patient assistance programs and public awareness in relation to patients with cancer, for pain management, for skin care, for management of diabetes, for management of asthma, for management of Chronic Obstructive Pulmonary Disease (COPD) and for management of respiratory diseases
45 Licensing of patents; licensing of trademarks; intellectual property licensing in the nature of licensing of intellectual property rights
44 Providing information in the field of medicine and health in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services; medical services in the field of oncology, pain management; dermatology, diabetology, respiratory disease and dietetic advisory services; medical assistance in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services; hygiene care for human beings in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and dietetic advisory services; medical clinic services; dietetic advisory services; disseminating medical information to patients for better lifestyle management to handle the treatment of side effects in the course of treatment of cancer, pain management, skin care, management of diabetes, management of asthma, Chronic Obstructive Pulmonary Disease (COPD) and respiratory diseases
10 Medical apparatus and instruments, namely, spirometers; medical devices, namely, nasal sprayers in the nature of nasal irrigation vessels, inhalers and nebulizers sold empty; medical devices, namely, autoanalysers; chromatographic medical diagnostic apparatus for testing cancer cells
42 Scientific research for medical purposes in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and biosimilars; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological services, namely, scientific research, analysis, testing in the field of oncology, immunology and pain management; medical research in the fields of oncology, immunology and pain management; clinical research in the fields of oncology, immunology and pain management; scientific research and development; [ pharmaceutical drug development services; pharmaceutical research and development; ] research and development for new products for others; chemical, pharmaceutical, nutraceutical and nutritional analysis and research; dermo-cosmetic and biotechnological analysis and research; design and testing for new product development; diagnostic product testing and analysis, namely, medical research and new product research for industrial use; scientific research in the fields of chemistry, biotechnology and pharmacology; medical and pharmaceutical research services, scientific research services for medical purposes, in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and biosimilars, bacteriological research services, biomedical research services, laboratory research services in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and biosimilars, clinical trial services in the nature of conducting clinical trials for others, pharmacological research services, medical research laboratory services in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and biosimilars, and scientific and technological services and research and design relating thereto, namely, scientific research, analysis, testing in the field of oncology, pain management, dermatology, diabetology, respiratory diseases and biosimilars
The mark consists of the stylized wording "ICHNOS" with three dots appearing on each side of the wording.
In the statement, Class 5,35 and 42, has been updated in accordance with the F-note dated 2/24/2022.
Color is not claimed as a feature of the mark.

Trademark Events
Nov 28, 2022
Invalidation Reviewed - No Action Required By Office
Nov 1, 2022
Partial Invalidation Of Reg Ext Protection Created
May 15, 2022
Final Decision Transaction Processed By Ib
Apr 27, 2022
Final Disposition Notice Sent To Ib
Apr 27, 2022
Final Disposition Processed
Mar 8, 2022
Correction From Ib Entered - No Review Required
Mar 1, 2022
Correction Under Section 7 ¿ Processed
Feb 23, 2022
Limitation From The Ib Examined, No Action Is Needed
Feb 9, 2022
Final Disposition Notice Created, To Be Sent To Ib
Feb 8, 2022
Otqr Withdrawal From Publication
Jan 27, 2022
Limitation From The Ib Examined And Entered
Jan 27, 2022
Correction Under Section 7 ¿ Processed
Jan 27, 2022
Assigned To Paralegal
Dec 25, 2021
Correction Transaction Received From Ib
Dec 25, 2021
Limitation Of Goods Received From Ib
Nov 9, 2021
Registered-Principal Register
Aug 24, 2021
Official Gazette Publication Confirmation E-Mailed
Aug 24, 2021
Published For Opposition
Aug 22, 2021
Notification Processed By Ib
Aug 4, 2021
Notification Of Possible Opposition Sent To Ib
Aug 4, 2021
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Aug 4, 2021
Notification Of Notice Of Publication E-Mailed
Jul 22, 2021
Approved For Pub - Principal Register
Jul 22, 2021
Teas/Email Correspondence Entered
Jul 22, 2021
Correspondence Received In Law Office
Jul 22, 2021
Assigned To Lie
Jul 9, 2021
Teas Response To Suspension Inquiry Received
Jul 3, 2021
Limitation Of Goods Received From Ib
Mar 6, 2021
Notification Of Letter Of Suspension E-Mailed
Mar 6, 2021
Letter Of Suspension E-Mailed
Mar 6, 2021
Suspension Letter Written
Mar 5, 2021
Teas/Email Correspondence Entered
Mar 5, 2021
Correspondence Received In Law Office
Mar 5, 2021
Teas Response To Office Action Received
Nov 7, 2020
New Representative At Ib Received
Sep 27, 2020
Refusal Processed By Ib
Sep 7, 2020
Non-Final Action Mailed - Refusal Sent To Ib
Sep 5, 2020
Refusal Processed By Mpu
Aug 8, 2020
Non-Final Action (Ib Refusal) Prepared For Review
Aug 7, 2020
Non-Final Action Written
Aug 4, 2020
Application Filing Receipt Mailed
Jul 31, 2020
Assigned To Examiner
Jul 31, 2020
New Application Office Supplied Data Entered In Tram
Jul 30, 2020
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24